Sangamo Therapeutics

0.6723
-0.0666
-9.01%
SGMO
高 0.7499开 0.7499量 583.83万股总市值 2.03亿
低 0.6700换 1.94%额 407.47万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
Sangamo Therapeutics(SGMO)
07-25 05:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020245  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
09-12 05:05  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 5.02 Accession Number: 0001001233-25-000011  Act: 34  Size: 143 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
10-10 06:55  
$Sangamo Therapeutics(SGMO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0002089213-25-000003  Size: 19 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-08 04:05  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-25-038855  Act: 34  Size: 328 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
07-25 05:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020242  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
07-25 05:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020243  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
07-25 05:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020244  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
07-25 05:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020246  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-27 08:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023077  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-27 08:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023071  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-27 08:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023074  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-08 04:15  
$Sangamo Therapeutics(SGMO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-25-038860  Act: 34  Size: 5 MB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-09 04:35  
$Sangamo Therapeutics(SGMO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-25-177017  Act: 33  Size: 190 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-27 08:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023081  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
08-27 08:05  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023079  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
09-04 20:15  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001001233-25-000006  Act: 34  Size: 6 MB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
10-01 04:05  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 5.02 Accession Number: 0001001233-25-000013  Act: 34  Size: 148 KB 网页链接